MRK vs PIPR · P/E 33, rev $16.61B vs P/E 26, rev $971.4M
Merck & Company Inc (MRK) versus Piper Sandler Companies (PIPR) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Piper Sandler Companies (PIPR) is a capital markets company listed on US.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported PIPR revenue for 2026-06-30 was $971.4M. Net income was $133.1M. PIPR currently screens at market cap $4.82B and trailing P/E 25.6.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. PIPR currently screens at market cap $4.82B and trailing P/E 25.6.
Not investment advice. Open the MRK and PIPR stock pages for the full models.
Not investment advice.